UROGEN PHARMA Trademark

Trademark Overview

On Wednesday, August 29, 2018, a trademark application was filed for UROGEN PHARMA with the United States Patent and Trademark Office. The USPTO has given the UROGEN PHARMA trademark a serial number of 88096670. The federal status of this trademark filing is SECTION 8 & 15 - ACCEPTED AND ACKNOWLEDGED as of Monday, December 1, 2025. This trademark is owned by UROGEN PHARMA LTD.. The UROGEN PHARMA trademark is filed in the Computer & Software Services & Scientific Services category with the following description:

Clinical research and development services in the field of uro-oncology
urogen pharma

General Information

Serial Number88096670
Word MarkUROGEN PHARMA
Filing DateWednesday, August 29, 2018
Status702 - SECTION 8 & 15 - ACCEPTED AND ACKNOWLEDGED
Status DateMonday, December 1, 2025
Registration Number5892686
Registration DateTuesday, October 22, 2019
Mark Drawing3 - Illustration: Drawing or design which also includes word(s) / letter(s) / number(s)
Published for Opposition DateTuesday, May 14, 2019

Trademark Statements

NOT AVAILABLE"PHARMA"
Goods and ServicesClinical research and development services in the field of uro-oncology
Indication of Colors claimedThe color(s) dark blue and light blue is/are claimed as a feature of the mark.
Description of MarkThe mark consists of of the word "UroGen", beneath it the word "Pharma", and to the left a stylized cross-sectional image of a human kidney. The letters "Gen" and the exterior of the kidney are in dark blue; the letters "Uro", the word "Pharma" and the interior of the kidney are in light blue.

Classification Information

International Class042 - Scientific and technological services and research and design relating thereto; industrial analysis and research services; design and development of computer hardware and software.
US Class Codes100, 101
Class Status Code6 - Active
Class Status DateFriday, September 7, 2018
Primary Code042
First Use Anywhere DateWednesday, October 31, 2018
First Use In Commerce DateWednesday, October 31, 2018

Trademark Owner History

Party NameUROGEN PHARMA LTD.
Party Type30 - Original Registrant
Legal Entity Type03 - Corporation
AddressRa'anana 4650073
IL
Party NameUROGEN PHARMA LTD.
Party Type20 - Owner at Publication
Legal Entity Type03 - Corporation
AddressRA'ANANA
IL
Party NameUROGEN PHARMA LTD.
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressRA'ANANA
IL

Trademark Events

Event DateEvent Description
Saturday, September 1, 2018NEW APPLICATION ENTERED
Friday, September 7, 2018NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Saturday, September 8, 2018NOTICE OF DESIGN SEARCH CODE E-MAILED
Wednesday, December 12, 2018ASSIGNED TO EXAMINER
Wednesday, December 19, 2018NON-FINAL ACTION WRITTEN
Wednesday, December 19, 2018NON-FINAL ACTION E-MAILED
Wednesday, December 19, 2018NOTIFICATION OF NON-FINAL ACTION E-MAILED
Monday, March 25, 2019TEAS RESPONSE TO OFFICE ACTION RECEIVED
Friday, March 29, 2019ASSIGNED TO LIE
Tuesday, April 2, 2019CORRESPONDENCE RECEIVED IN LAW OFFICE
Tuesday, April 2, 2019TEAS/EMAIL CORRESPONDENCE ENTERED
Friday, April 5, 2019APPROVED FOR PUB - PRINCIPAL REGISTER
Wednesday, April 24, 2019NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Monday, April 29, 2019TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Monday, April 29, 2019ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Tuesday, May 14, 2019PUBLISHED FOR OPPOSITION
Friday, May 17, 2019NOTICE OF PUBLICATION
Thursday, June 27, 2019TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Thursday, June 27, 2019ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Tuesday, July 9, 2019NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Friday, August 16, 2019TEAS STATEMENT OF USE RECEIVED
Saturday, September 14, 2019CASE ASSIGNED TO INTENT TO USE PARALEGAL
Friday, August 16, 2019USE AMENDMENT FILED
Saturday, September 14, 2019STATEMENT OF USE PROCESSING COMPLETE
Monday, September 16, 2019ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED
Tuesday, September 17, 2019NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED
Tuesday, October 22, 2019REGISTERED-PRINCIPAL REGISTER
Thursday, May 21, 2020TEAS CHANGE OF OWNER ADDRESS RECEIVED
Thursday, May 21, 2020TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Thursday, May 21, 2020ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Thursday, May 21, 2020TEAS CHANGE OF DOMESTIC REPRESENTATIVES ADDRESS
Thursday, May 21, 2020TEAS CHANGE OF CORRESPONDENCE RECEIVED
Thursday, May 21, 2020APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
Friday, June 19, 2020REVIEW OF CORRESPONDENCE COMPLETE - ADDRESS UPDATED
Friday, February 19, 2021TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Friday, February 19, 2021ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Friday, February 19, 2021TEAS CHANGE OF CORRESPONDENCE RECEIVED
Tuesday, October 22, 2024COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED
Monday, March 10, 2025TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Monday, March 10, 2025ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Monday, March 10, 2025TEAS CHANGE OF DOMESTIC REPRESENTATIVES ADDRESS
Monday, March 10, 2025TEAS CHANGE OF CORRESPONDENCE RECEIVED
Monday, March 10, 2025TEAS WITHDRAWAL OF ATTORNEY RECEIVED-FIRM RETAINS
Tuesday, August 19, 2025TEAS SECTION 8 & 15 RECEIVED
Monday, December 1, 2025CASE ASSIGNED TO POST REGISTRATION PARALEGAL
Monday, December 1, 2025REGISTERED - SEC. 8 (6-YR) ACCEPTED & SEC. 15 ACK.
Monday, December 1, 2025NOTICE OF ACCEPTANCE OF SEC. 8 & 15 - E-MAILED

Related Keywords

pharma urogen field oncology services development research clinical